Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Irinotecan hydrochloride
Medication labelONIVYDE is indicated, in combination with oxaliplatin, fluorouracil and leucovorin for the first-line treatment of adult patients with…
Why this: Advisory · dailymed-prescription
ONIVYDE is indicated, in combination with oxaliplatin, fluorouracil and leucovorin for the first-line treatment of adult patients with metastatic pancreatic adenocarcinoma. ONIVYDE is indicated, in combination with fluorouracil and leucovorin, for the treatment of adult patients with metastatic pancreatic adenocarcinoma after disease progression following gemcitabine-based therapy. Limitations of Use: ONIVYDE is not indicated as a single agent for the treatment of patients with metastatic pancreatic adenocarcinoma. [see Clinical Studies (14)].
- generic_name
- irinotecan hydrochloride
- product_names
- IRINOTECAN HYDROCHLORIDE
- ndc
- 15054-0043, 15054-0043-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en